|Articles|September 7, 2021
Design of Experiments in Upstream Bioprocessing
Author(s)Distek, Inc
In this work we demonstrate the effectiveness of Design of Experiment methodology for upstream process development through the execution of transient gene expression optimization and oxygen mass transfer characterization studies.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
Developing Next-Gen Cell Lines Using Targeted Integration
4
FAQ: Shifts in FDA Regulations and Strategies in 2025
5
